pomalidomide,dexamethasone
bms
[' pom ', 'multiple myeloma']
initial clinical data presented at #ash22 p300/cbp inhibitor, inobrodib treating heavily pre-treated relapsed refractory multiple myeloma. 
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.